Canada - Healthcare, Regulatory and Reimbursement Landscape

Canada - Healthcare, Regulatory and Reimbursement Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report: “Canada - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Canada. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The growth in Canada's pharmaceutical market is attributed to the adoption of R&D activities towards advanced therapies and increased partnerships among pharmaceutical companies and academia, small and medium-sized enterprises (SMEs), government, and research centers. In 2020, the Canadian pharmaceutical market was the ninth largest globally in terms of value. Canada’s pharmaceutical market, based on production value, $23.86 billion in 2013 increased to $25.55 billion in 2020 at a Compound Annual Growth Rate (CAGR) of 0.98%. It is forecast to reach about $27.08 billion in 2026. In 2016, the medical devices market in Canada was worth $8.02 billion, which increased at a CAGR of 6.09% to $10.79 billion in 2021. It is expected to grow at a CAGR of 3.96% from 2022 to reach $12.96 billion in 2027.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Canada, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Johnson & Johnson, Novartis, Abbvie, Ceapro, and Thera technologies.
• Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Boston Scientific, Bausch Health, and AlphaProTech.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in the Canadian healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving Canadian healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Canadian healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership